Helping People Live Healthier, More Productive Lives
As a contract development and manufacturing organization (CDMO), we work closely with our customers to deliver proven, highly engineered products that help millions of people live healthier, more productive lives.
Our 60+ years of expertise and the backing of one of the largest privately held companies in the world allow us to focus on long-term, mutually beneficial solutions for our customers, employees and communities.
Who We Are
The engineers at Phillips Medisize, a privately owned, global CDMO, collaborate with industry leaders and innovators to design and manufacture drug delivery systems, medical devices and diagnostic tools that save and improve the quality of life for millions of patients annually.
With our dedicated team of 6,000+ employees and 30 development and manufacturing sites across three continents, we put the patient at the center of all we do, knowing that every decision is critical to a healthcare provider and their patients somewhere in the world.
Phillips Medisize is a Molex company, and Molex—a global electronics brand that serves many sectors, including healthcare—is owned by Koch, one of the largest privately held companies in the world with annual revenue exceeding $125 billion* and 120,000 employees in approximately 60 countries.
A Global Medical CDMO for an Increasingly Complex Medical Market
Backed by the scale, investment, flexibility and stability of private ownership, Phillips Medisize offers deep design, quality and manufacturing expertise for pharmaceutical, medical technology and in vitro diagnostic devices.
6,000
Employees Worldwide
60+
Years Of Innovation
30
Global Locations
11
Countries
7
Innovation Centers
1.6B+
Annual Revenue
What We Do
From discovery to delivery with our customers, we achieve our vision by:
- Leveraging our differentiated design, development and manufacturing capabilities
- Embracing the Principle-Based Management™ framework, driving continuous improvement and producing the highest quality outcomes
- Investing in talent and new technologies that benefit our customers, colleagues and communities
Who We Serve
We believe the C in CDMO also represents care—the care we take in engineering products and the care these devices ultimately deliver to patients. We are privileged to serve our customers in a tailored, highly personalized way. We listen, ask questions and embrace engineering challenges. While we are proud of the many customers that we have helped in the past 60 years, in just the last few years alone, we have collaborated with:
54%
of the 13 pharmaceutical companies on the 2024 Fortune 500 list1
80%
of the Top 10 valuable pharma companies2
100%
of the nine medical product and equipment companies on the 2024 Fortune 500 list1
100%
of the Top 10 valuable med device companies2
Featured Resources
*Our revenues fluctuate with the price of commodities. They have been as high as $125 billion.
1. Healthcare 2024. Brand Finance. https://brandirectory.com/rankings/pharma. Accessed November 2024.
2. Medical devices 25 2024 ranking. Brand Finance. https://brandirectory.com/rankings/medical-devices. Accessed November 2024.